Search
With one of the largest healthy volunteer databases and advanced infrastructure spread across three clinical facilities, we deliver precision in pharmacokinetic (PK) and pharmacodynamics (PD) studies.
We have been trusted by leading regulators from the US and Europe to meet the highest compliance standards. Your drug’s dosing, safety, and tolerability assessments are in expert hands, ensuring compliance and scientific rigor.
Our extensive network of hospitals and investigators empowers us to excel in patient pharmacokinetic (PK)/ pharmacodynamic (PD) and clinical endpoint studies across varied therapeutic areas.
From oncology to psychiatry and dermatology, our recruitment process emphasizes eligibility and patient safety. Our clear, informed consent process ensures that patients fully understand the trial details while prioritizing their well-being and ethical considerations.
At Veeda Lifesciences, we ensure that every bioanalytical method used in our bioavailability (BA) and bioequivalence (BE) studies is rigorously validated for accuracy, sensitivity, and specificity.
Our expert team employs these validated methods to analyze samples, delivering precise data essential for evaluating the pharmacokinetic properties of your drug.
Developing complex generics requires a nuanced approach and expertise that goes beyond standard generics. Our scientists bring years of experience, a deep understanding of advanced analytical techniques, and regulatory knowledge to ensure safety, efficacy and bioequivalence for challenging drugs like long-acting injectables and inhalation products.
In today’s environment of rising costs, and tighter regulations, we pride ourselves on delivering solutions that maintain the value and profitability of complex generics.
We craft protocols with precision, ensuring a smooth and efficient study process.
We create scientifically rigorous study designs carefully tailored to minimize bias, control experimental variables, and ensure precise results – whether single-dose or multiple-dose studies, we get the right approach for you.
Leveraging a vast volunteer database, we ensure high recruitment rates, optimize volunteer retention, and minimize variability by matching demographics with safety and usage criteria for your product.
Our focused strategies ensure a steady flow of qualified participants, keeping your study on track despite potential dropouts.
From initiation to administration, we manage the investigational product lifecycle with a keen eye for detail.We oversee logistics dosing protocols and ensure compliance with all requirements, keeping your study running smoothly and ensuring precise, actionable results.
We expertly navigate the regulatory landscape, preparing comprehensive submissions for local regulatory bodies to ensure smooth, compliant study execution.
Our team handles all the paperwork and processes, ensuring compliance while streamlining approval timelines so your study progresses without delays.
We meticulously manage blood sample collection, ensuring that all sampling schedules are followed to the letter.
This reduces variability, guaranteeing that the data collected is consistent and reliable, which is critical for validating your product’s efficacy.
Our protocols prioritize volunteer safety and compliance, ensuring that study conditions—from diet to posture—are adhered to throughout. This ensures the results are not skewed by external factors and that the study integrity remains intact.
With a comprehensive statistical analysis plan, we apply proven methodologies to analyze your data, ensuring that every result is meaningful, valid, and actionable.
Our final study reports provide transparency and clarity for both regulatory submissions and strategic decisions.
Conducted 5000+ Healthy Volunteer Studies BA/BE Studies
Database of 89,000+ Volunteers
1250+ Analytical Methods in Place
Strict Quality Management System is in place to capture any non-compliance or deviation
Inspected By USFDA, AGES, MHRA, ANVISA, WHO, EMA & others
Insights into the impact of Orally Inhaled Drug Products on driving the primary and secondary endpoints of COPD trials.
Take a look at the key steps we take to conduct successful studies for complex drugs like Liraglutide
From preclinical to late phase trials, Veeda Group combines advanced technology, global expertise, and agility to streamline every stage of drug development.
